A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur "catastrophic" health costs, ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays.

In a new study, researchers have developed a dry powder inhalation form of CBD that may help treat conditions like chronic ...

Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from ...

Century Health, a pioneer in applying AI to real-world data to accelerate research, and Nimbus Health, a technology-driven pulmonary care provider transforming how lung conditions are managed, today ...

Men, particularly after the age of 35, face a higher risk of developing chronic illnesses than women. While genetics and ageing play a role, many of these conditions are largely influenced ...

Regeneron's Dupixent leads growth as Eylea sales decline and valuation is attractive, but growth is delayed by 2-3 years.

A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur 'catastrophic' health costs, new research published ...

Schuylkill’s emergency room raised concerns about the impact of the recent heat wave on the health of people with ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

I was assigned to Medicine Team 6 (MT6)—our residency program’s only inpatient family medicine service. It’s not just another ...

Find Harvard University Scientist Latest News, Videos & Pictures on Harvard University Scientist and see latest updates, news, information from NDTV.COM. Explore more on Harvard University Scientist.